TAM
DNA icon

Titleist Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Titleist Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-71,200
Closed -$699K – 304
2024
Q4 		$699K Hold
71,200
– – 0.08% 160
2024
Q3 		$580K Buy
71,200
+69,420
+3,900% +$696K 0.08% 160
2024
Q2 		$23.8K Hold
1,780
– – ﹤0.01% 261
2024
Q1 		$83 Buy
+1,780
New +$92.1K ﹤0.01% 256
2023
Q3 		– Sell
-3,150
Closed -$235 – 218
2023
Q2 		$235 Hold
3,150
– – ﹤0.01% 224
2023
Q1 		$168 Buy
+3,150
New +$200K ﹤0.01% 220

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Titleist Asset Management's DNA Position: Q1 2025 in Review

Titleist Asset Management sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 30,961 shares — an estimated $304K sold.

Titleist Asset Management first reported a position in DNA in Q1 2023 and held it in 8 quarters. The position peaked at $4.71M in Q2 2023. 165 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

  • Titleist Asset Management reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
  • Titleist Asset Management sold 30,961 Ginkgo Bioworks shares in Q1 2025, an estimated $304K.
  • Titleist Asset Management first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 8 quarters.
  • Titleist Asset Management's Ginkgo Bioworks position peaked at $4.71M in Q2 2023.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on Titleist Asset Management's 13F filing for Q1 2025, filed 15 May 2025.